Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FPRH4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $49,449.30 by the Defense Logistics Agency on September 4, 2025, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, with an ultimate completion date of September 25, 2025, carries no set-aside designation and will be performed at the contractor's Park Ridge location. The award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through the SPE2DB program, which authorizes the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
As a established federal pharmaceutical supplier since 2001, DMS Pharmaceutical Group maintains a robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables for Department of Defense healthcare systems. The Entyvio delivery supports the agency's pharmaceutical supply chain requirements, providing direct distribution of specialty medications to military health facilities. The contractor's status as a woman-owned small business and its long-standing relationship with the Defense Logistics Agency position it as a critical supplier within the federal pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DB25FPRH4?
SPE2DB25FPRH4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FPRH4 worth?
The government has obligated $49,449 on SPE2DB25FPRH4.
Is contract SPE2DB25FPRH4 an order under another contract?
Yes. SPE2DB25FPRH4 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRH4 competed?
The extent of competition for SPE2DB25FPRH4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award